When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules
A large health system absorbs an appeal as routine. For a small agency with a…
A large health system absorbs an appeal as routine. For a small agency with a few office staff, every hour chasing a physician signature or a face-to-face note is an hour not spent on patients. The post When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules appeared first on…
Users are, rightfully, upset that the devices they bought are not delivering the results they were promised. But is that indignation pointed at the right flaw? The post Beyond Metrics: How to Repair Our Relationship With Wearables appeared first on MedCity News.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF. This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0…
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF. This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0…
By ANDREW TSANG (Part 1 is here) The Healthcare Economy’s Smoking Gun That is the generous side of the accounting, where healthcare produces benefits other industries get to keep. The other side coming in shows that healthcare treats damage other industries get paid to cause. Due to size alone, tobacco use is the best example….
Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals. The post Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy appeared first on MedCity News.
Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide. The post Maven Clinic’s Virtual Care Clinic Goes In Network with 475 Plans appeared first on MedCity News.
Democrats’ huge wins last week might mean big changes coming to healthcare across the country, especially in states which flipped blue. How might the shift in power affect affordability, access, and coverage? The post Democrats’ Midterm Wins Could Reshape Healthcare Access for Underserved Americans appeared first on MedCity News.
[Sponsored] In an interview, Wayne Luan, senior director, life sciences and provider solutions with Turquoise Health, told MedCity News Editor-in-Chief Arundhati Parmar that the company’s platform provides pricing data for medical services, medical devices, and pharmaceutical drugs. The post Can an Infrastructure for Price Transparency Improve Healthcare Competition and Quality? appeared first on MedCity News.
The deal would extend services to more than 2,000 hospitals and 240,000 prescribing providers